Welcome to our dedicated page for CONCENTRA GROUP HOLDINGS PAREN SEC filings (Ticker: CON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Healthcare filings can feel like medical charts: dense, technical, and mission-critical. Concentra Group Holdings Parent Inc.’s disclosures weave together workers’ compensation statutes, telemedicine economics, and clinic utilization data—details investors hunt for yet rarely find quickly. If you have ever typed “Concentra Group Holdings Parent Inc. SEC filings explained simply” or searched for the next “Concentra Group Holdings Parent Inc. quarterly earnings report 10-Q filing,” you already know the challenge.
Stock Titan solves it. Our AI reads every line of the Concentra Group Holdings Parent Inc. annual report 10-K simplified, highlights segment profitability, and flags compliance risks in seconds. Need real-time alerts? We stream “Concentra Group Holdings Parent Inc. Form 4 insider transactions real-time,” so you can track executive stock transactions before the market reacts. Interactive dashboards turn pages of accounting notes into clear charts, while plain-English summaries answer the question: “What changed this quarter?”
The platform covers every filing type the moment it hits EDGAR: 10-K, 10-Q, 8-K material events explained, Form 4 insider trading transactions, and the proxy statement executive compensation breakdown. Use AI-powered summaries to compare clinic revenue trends, monitor workers’ comp claim costs, or assess telemedicine adoption—all without wading through footnotes. Whether you’re performing a Concentra Group Holdings Parent Inc. earnings report filing analysis or simply understanding Concentra Group Holdings Parent Inc. SEC documents with AI, our tools let you move from data to decision faster.
Concentra Group Holdings Parent, Inc. (CON) reported an insider equity award. The company’s Chief Executive Officer and Director acquired 225,000 shares of common stock on 11/04/2025 via a grant coded “A”. The filing lists a $0 price, consistent with a restricted stock award.
The award is described as restricted stock that will vest in equal annual installments over four years. Following this transaction, the reporting person beneficially owned 482,831 shares, held directly.
Concentra Group Holdings Parent, Inc. (CON) reported an insider equity award. Executive Vice President & Chief Legal Counsel Timothy F. Ryan acquired 60,000 shares of common stock on 11/04/2025 as a restricted stock grant at $0.
The award will vest in equal annual installments over four years. Following the grant, Ryan beneficially owned 120,000 shares, held directly.
Concentra Group Holdings Parent (CON) reported a director equity award on a Form 4. On November 4, 2025, the director received two grants of common stock: 7,748 shares that vest in equal annual installments over five years, and 7,748 shares that vest in full on November 4, 2026, subject to certain exceptions. The reported transaction price was $0, reflecting restricted stock awards. Following these grants, the director beneficially owns 15,496 shares, held directly.
Concentra Group Holdings Parent, Inc. (CON) reported an insider equity grant. On November 4, 2025, an officer acquired 60,000 shares of common stock as a restricted stock award at $0, scheduled to vest in equal annual installments over four years.
After this grant, the reporting person beneficially owns 120,000 shares, held directly. The officer’s title is Executive Vice President, Chief Operating Officer - West.
Concentra Group Holdings Parent, Inc. reported an insider equity award to a director.
On 11/04/2025, 7,748 shares of common stock were acquired at $0 (Transaction Code A). Per the footnote, this was a grant of restricted stock that will vest in full on November 4, 2026.
Following the grant, 5,533,794 shares were beneficially owned directly. Indirect holdings include 1,023,455 shares by The Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio and 1,032,115 shares by the Robert A. Ortenzio Descendants Trust.
Concentra Group Holdings Parent, Inc. (CON) reported an insider equity award on a Form 4. The company’s Executive Vice President, Chief Marketing and Innovation Officer received 60,000 shares of common stock on 11/04/2025 via a restricted stock grant at $0 per share.
The restricted stock will vest in equal annual installments over four years. After this grant, the reporting person beneficially owns 120,000 shares, held directly.
Concentra Group Holdings Parent, Inc. disclosed a Form 4 for its Senior Vice President, Human Resources, showing an award of 40,000 shares of common stock on 11/04/2025. The award is restricted stock that will vest in equal annual installments over four years at a price of $0.
After this grant, the reporting person beneficially owns 80,000 shares, held directly.
Concentra Group Holdings Parent, Inc. (CON) insider transaction: On 11/04/2025, the Executive Vice President and Chief Accounting Officer received a grant of 60,000 shares of common stock at $0 as restricted stock. The award will vest in equal annual installments over four years.
Following this grant, the officer beneficially owns 120,000 shares, held directly.
Concentra Group Holdings Parent, Inc. (CON) filed a Form 4 reporting an executive equity grant. On 11/04/2025, the Executive Vice President and Chief Medical Officer received 60,000 shares of common stock as a restricted stock award at a reported price of $0.
The restricted stock will vest in equal annual installments over four years. Following this grant, the reporting person beneficially owns 120,000 shares, held directly.
Concentra Group Holdings Parent, Inc. (CON) reported an insider equity grant. On 11/04/2025, an officer received 60,000 shares of common stock at a price of $0 under a restricted stock award. Following the grant, the officer beneficially owns 120,000 shares, held directly.
The award is described as restricted stock that will vest in equal annual installments over four years. The reporting person is identified as Executive Vice President, Chief Growth & Customer Officer. The transaction was coded as an acquisition of securities.
FAQ
What is the current stock price of CONCENTRA GROUP HOLDINGS PAREN (CON)?
What is the market cap of CONCENTRA GROUP HOLDINGS PAREN (CON)?
